Recent findings show support for the development of monoclonal antibody CSX-1004 as a therapeutic to prevent and reverse fentanyl-induced overdose. There are 70,000 overdose deaths each year in the US due to the opioid crisis.

Recent findings show support for the development of monoclonal antibody CSX-1004 as a therapeutic to prevent and reverse fentanyl-induced overdose. There are 70,000 overdose deaths each year in the US due to the opioid crisis.